Jeremy Stigall

EVP & General Manager, Biologics & Drug Delivery at ClearPoint Neuro

Jeremy joined ClearPoint Neuro in July 2020. He is a proven leader in the medical device industry with over 20 years of experience, starting his career at Guidant Corporation and Abbott Vascular, holding various positions within R&D, Engineering and Operations. Jeremy was responsible for the development and commercialization of several key stent delivery systems and drug eluting stent platforms. He has since held various positions managing cross functional groups of Scientists and Engineering Leaders at Volcano Corporation and Philips, most recently as the Technical Leader and Director of R&D. As a Director, he managed a global team responsible for advanced development, new product introductions for the Coronary, Peripheral & Heart Rhythm business units as well as establishing value creation within the devices business. Jeremy played a key role in the acquisition of several companies which were integrated into the Philips strategic plan and has provided organizational diligence towards many strategic investments as well as a key information provider in the transactional strategies. In addition to providing organizational direction, Jeremy managed the technical experts within engineering in the field of Electrical, Mechanical, Biomedical, Acoustics, Physics, Material Science and Transducing. As an innovator in the medical device space, Jeremy currently holds 30+ granted patents in the US and has several key patents pending.